Patient characteristics and real-world outcomes among atrial fibrillation patients treated with direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in Spain
30 March 2025 (08:00 - 15:30)
Organised by: 
About the speaker
12th of October University Hospital, Madrid (Spain)
139 More presentations in this session
Doctor A. Zienciuk-Krajka (Gdansk, PL)
Assistant Professor F. Guerra (Ancona, IT)
Access the full session
The Event
EHRA 2025
30 March - 1 April 2025
You may be interested in
Congress Presentation
